|
|
|
Sunday, February 27, 2011 — 8:30 a.m., CC 102 A/B
|
|
|
Moderator:
|
S. David Hudnall, Yale University School of Medicine, New
Haven, CT
|
|
|
Disclosure:
|
In accordance with ACCME guidelines regarding disclosure, the USCAP policy requires that faculty members who have a significant financial or other relationship with a commercial company, entity, or service (which will be discussed in this Symposium) must disclose this to attendees. The Academy also requires that speakers disclose any products that are not labeled for the use under discussion. The speakers listed below have indicated they have nothing to disclose. |
Click the button above to add this event to your Itinerary Planner...
| 8:30 |
Introduction:
- S. David Hudnall, Yale University School of Medicine, New Haven, CT |
| 9:00 |
EBV and Cancer
- Lawrence M. Weiss, City of Hope, Duarte, CA |
| 9:30 |
MCV and Cancer
- Yuan Chang, University of Pittsburgh Cancer Institute, Pittsburgh, PA |
| 10:00 | Break |
| 10:30 |
HPV and Cancer
- Peter M. Howley, Harvard Medical School, Boston, MA |
| 11:00 |
HTLV1 and Cancer
- Koichi Ohshima, Kurume University, Kurume, Japan |
| The topic was chosen by the Educational Committee of the Binford-Dammin Society. The topic deals with a scientifically interesting and clinically important issue, i.e. the role of infectious human viruses in the cause of cancer. Tumor viruses have evolved mechanisms not only for infecting human tissues but also to transform infected cells. In some cases, transformation leads to malignancy. The speakers, each one of them an internationally recognized expert, will review the mechanism of virus transformation, the pathology and epidemiology of related malignant disease, and the role of pathology in viral detection and tumor diagnosis. |
|
|
|
